ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2025

Zinzino group revenue increased with a total of 54 %, compared with the previous year.

 

The revenue in May for Zinzino's sales markets increased by 58 % and amounted to SEK 277.6 (175.5) million. Faun Pharma's external sales decreased and amounted to SEK 7.6 (9.5) million. Overall, the Group increased revenues by 54 % to SEK 285.2 (185.0) million compared with the previous year.

Accumulated revenue for January – May 2025 increased by 57 % to SEK 1,261.7 (805.6) million.

Revenues were distributed as follows:

Regions,MSEK	25-May	24-May	Change	YTD 2025	YTD 2024	Change
The Nordics	29.3	25.7	14%	129.8	118.8	9%
Central Europe	74.0	49.5	49%	335.1	214.5	56%
East Europe	36.7	34.8	5%	161.1	159.6	1%
South & West Europe	49.3	34.2	44%	218.1	131.2	66%
The Baltics	11.5	8.8	31%	48.8	40.8	20%
North America	47.3	16.4	188%	212.1	67.1	216%
Asia-Pacific	27.5	4.8	473%	118.5	22.6	424%
Africa	2.0	1.3	54%	8.5	5.7	49%
Zinzino	277.6	175.5	58%	1,232.0	760.3	62%
Faun Pharma	7.6	9.5	-20%	29.7	45.3	-34%
Zinzino Group	285.2	185.0	54%	1,261.7	805.6	57%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: DNB Carnegie Investment Bank AB (publ.)